$0.28-0.15 (-34.66%)
Baird Medical Investment Holdings Ltd (BDMD) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for BDMD, including 3 press releases and news items and 2 SEC filings. The most recent was published Oct 19, 2026.
Price$0.28-0.15 (-34.66%)
01:30 PM07:45 PM
News · 26 weeks25-67%
2026-05-032026-10-25
Mix1990d
- Other11(58%)
- SEC Filings7(37%)
- Insider1(5%)
Latest news
25 items- PRBaird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation TechnologyNEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in microwave ablation (MWA) technology, today announced additional medical device registrations in Vietnam and preliminary regulatory approval in Egypt. The preliminary approval in Egypt will help the Company bring its technology to one of the largest markets in the Middle East, while the product registrations in Vietnam will enable Baird to expand the addressable patient population in this key Southeast Asian country. These milestones reflect the continued successful execution of the Company’s international growth and diversification strat
- PRBaird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company") (NASDAQ:BDMD), a medical device company focused on the development and commercialization of minimally invasive treatment technologies, today highlighted key business and operational developments from the third quarter of 2026, including expansion into new international markets, continued physician training initiatives and the addition of irreversible electroporation (IRE) technology to its broader technology portfolio through a strategic partnership. "During the third quarter, we continued to execute on the priorities that we believe will drive Baird Medical’s long-term gr
- SECSEC Form SCHEDULE 13G filed by Baird Medical Investment Holdings LtdSCHEDULE 13G - Baird Medical Investment Holdings Ltd (0001982444) (Subject)
- SECSEC Form 6-K filed by Baird Medical Investment Holdings Ltd6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form 6-K filed by Baird Medical Investment Holdings Ltd6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form 424B5 filed by Baird Medical Investment Holdings Ltd424B5 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- PRBaird Medical to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceNEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company") (NASDAQ:BDMD), a global medical technology company focused on the development and commercialization of minimally invasive treatment solutions, today announced that management will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City. H.C. Wainwright 28th Annual Global Investment ConferenceDate: Wednesday, September 16, 2026Time: 11:30 a.m. ETLocation: Lotte New York Palace Hotel, New York City A live webcast of the presentation will be available through the Investor Relations section of Baird Medical’s website, and a replay will be
- PRBaird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation TechnologyCOPENHAGEN, Denmark, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company") (NASDAQ:BDMD), a global medical technology company focused on the development and commercialization of minimally invasive treatment solutions, today highlighted its participation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2026 Annual Congress, held at the Bella Center Copenhagen. Throughout the congress, Baird Medical showcased its Microwave Ablation (MWA) System to interventional radiologists and healthcare professionals from around the world, providing an opportunity to engage with the global medical community and demons
- SECSEC Form 6-K filed by Baird Medical Investment Holdings Ltd6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- PRBaird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), today announced preliminary unaudited financial results for the six months ended June 30, 2026. Revenue for the first half of 2026 was approximately $9.9 million, an increase of 24.6% over $8.0 million reported for the six months ended June 30, 2025. The increase in revenue was primarily attributable to growth outside of the People’s Republic of China, including in the United States, as well as licensing revenue. Approximately two thirds of revenue for the period was generated from markets outside of the PRC, with Hong Kong and the U.S. being the main contr
- PRBaird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in PakistanNEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), announced that the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from the Drug Regulatory Authority of Pakistan ("DRAP"), further supporting the Company’s commercial activities in the country. The registrations build on Baird Medical’s existing presence in Pakistan, where the Company announced regulatory approvals and initial commercial availability at the Armed Forces Institute of Radiology & Imaging ("AFIRI") in January 2026. The latest registrations further expand the regulatory foundat
- SECSEC Form 424B3 filed by Baird Medical Investment Holdings Ltd424B3 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form EFFECT filed by Baird Medical Investment Holdings LtdEFFECT - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form EFFECT filed by Baird Medical Investment Holdings LtdEFFECT - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- PRBaird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology GloballyAgreement combines Baird Medical's clinical, regulatory, and global commercialization expertise with Alpmed's leadership in IRE technologyCollaboration will advance technology development, global regulatory approvals, commercialization, and clinical adoption across key international markets, including the United States NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company") and Tianjin Yuanshan Medical Technology Co., Ltd., operating under the Alpmed brand ("Alpmed"), a China-based innovator in irreversible electroporation ("IRE") technology, announced the signing of a strategic cooperation agreement to establish
- SECSEC Form POS AM filed by Baird Medical Investment Holdings LtdPOS AM - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECAmendment: SEC Form F-3/A filed by Baird Medical Investment Holdings LtdF-3/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form SCHEDULE 13D filed by Baird Medical Investment Holdings LtdSCHEDULE 13D - Baird Medical Investment Holdings Ltd (0001982444) (Subject)
- INSIDERNew insider Excelfin Spac Llc claimed ownership of 7,004,016 units of Ordinary shares (SEC Form 3)3 - Baird Medical Investment Holdings Ltd (0001982444) (Issuer)
- SECAmendment: SEC Form 20-F/A filed by Baird Medical Investment Holdings Ltd20-F/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- PRBaird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and ArgentinaFirst procedures in two new markets highlight growing global adoption of Baird Medical's minimally invasive microwave ablation technology NEW YORK, June 29, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of the first procedures using its MWA technology in Vietnam and Argentina. In Vietnam, the first clinical case using the Company's MWA technology was completed at Lac Viet Friendship Hospital on June 18. The procedure was performed by Dr. Dinh Xuan H
- PRBaird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial ExpansionEnhanced U.S. Presence Centralizes Operations as Company Executes Global Growth StrategyNEW YORK, June 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the relocation of its global headquarters to the U.S., with the establishment of a new corporate office in New York, NY. The relocation follows the December 2025 appointment of Mark Saxton as CEO of Baird Medical's U.S. subsidiary to lead domestic operations, commercial expansion, and market development, establishing a Compan
- SECSEC Form POS AM filed by Baird Medical Investment Holdings LtdPOS AM - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form F-3 filed by Baird Medical Investment Holdings LtdF-3 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)
- SECSEC Form SCHEDULE 13G filed by Baird Medical Investment Holdings LtdSCHEDULE 13G - Baird Medical Investment Holdings Ltd (0001982444) (Subject)
BDMD FAQ
5 questionsWhat is the latest news on BDMD?
In the last 30 days Quantisnow tracked 5 wire items for BDMD: 3 press releases and news items and 2 SEC filings. The most recent was published on October 19, 2026.Where does BDMD stock trade?
Baird Medical Investment Holdings Ltd (BDMD) is listed on NASDAQ.What sector and industry is BDMD in?
Baird Medical Investment Holdings Ltd operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to BDMD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare BDMD side-by-side with any of them on Quantisnow.How can I track BDMD on Quantisnow?
Quantisnow aggregates Baird Medical Investment Holdings Ltd's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BDMD to receive live email and push alerts on every new disclosure.